We are live on ! Find out more
GCL

Glazer Capital LLC Portfolio holdings

AUM $4.71B
1-Year Est. Return 81.93%
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
+81.93%
3 Year Est. Return
+319.13%
5 Year Est. Return
+526.52%
10 Year Est. Return
+4,797.43%
AUM
$3.86B
AUM Growth
-$1.59B
Cap. Flow
-$1.68B
Cap. Flow %
-43.43%
Top 10 Hldgs %
19.14%
Holding
821
New
112
Increased
267
Reduced
93
Closed
295
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTAA
51
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
$24.6M 0.64%
2,436,273
+583,530
+31% +$5.84M
JCIC
52
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
$24.3M 0.63%
2,398,760
-1,036,150
-30% -$10.4M
FINM
53
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$24.3M 0.63%
2,395,768
+834,857
+53% +$8.38M
NRAC
54
DELISTED
Northern Revival Acquisition Corporation Class A Ordinary Share
NRAC
$24.2M 0.63%
2,397,045
+7,303
+0.3% +$73.2K
MSDA
55
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
$23.7M 0.61%
2,347,648
+1,867,481
+389% +$18.7M
IVCB
56
DELISTED
Investcorp Europe Acquisition Corp I Class A Ordinary Shares
IVCB
$23.5M 0.61%
2,283,265
+84,664
+4% +$864K
PACX
57
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$23.1M 0.6%
2,281,787
+1,189,317
+109% +$11.9M
BIOT
58
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$23.1M 0.6%
2,283,910
-1,090
-0% -$10.9K
QDRO
59
DELISTED
Quadro Acquisition One Corp. Class A Ordinary Shares
QDRO
$23M 0.59%
2,274,961
+24,503
+1% +$245K
AEAC
60
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
$22.9M 0.59%
2,270,000
+722,860
+47% +$7.25M
ASBP
61
Aspire Biopharma
ASBP
$8.7M
$22.9M 0.59%
1,854
+94
+5% +$1.15M
ITQ
62
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
$22.9M 0.59%
2,265,314
+56,905
+3% +$570K
SVFB
63
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$22.6M 0.58%
2,234,949
+1,091,267
+95% +$10.9M
FRON
64
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$22.1M 0.57%
2,191,435
+919,361
+72% +$9.2M
LDHA
65
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
$22M 0.57%
2,189,612
+384,652
+21% +$3.84M
MCAA
66
DELISTED
Mountain & Co. I Acquisition Corp. Class A Ordinary Shares
MCAA
$21.4M 0.55%
2,059,573
+789,033
+62% +$8.14M
ZLS
67
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$21.2M 0.55%
2,118,250
+2,115,750
+84,630% +$21M
BCSA
68
DELISTED
Blockchain Coinvestors Acquisition Corp. I Class A Ordinary Shares
BCSA
$20.8M 0.54%
2,033,653
+1,598,293
+367% +$16.2M
TWOA
69
DELISTED
two
TWOA
$20.6M 0.53%
2,048,953
+829,192
+68% +$8.28M
DLCA
70
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$20.6M 0.53%
2,043,878
+294,789
+17% +$2.96M
CURR
71
Currenc Group
CURR
$365M
$20.2M 0.52%
1,947,475
+800,595
+70% +$8.21M
DHAI
72
DELISTED
DIH Holdings US
DHAI
$20.1M 0.52%
78,638
-765
-1% -$194K
WQGA
73
DELISTED
World Quantum Growth Acquisition Corp.
WQGA
$20M 0.52%
1,960,314
+740,523
+61% +$7.49M
OPA
74
DELISTED
Magnum Opus Acquisition Limited
OPA
$19.9M 0.51%
1,973,108
+527,401
+36% +$5.27M
FAAS
75
DELISTED
DigiAsia
FAAS
$19.9M 0.51%
1,935,932
+851,278
+78% +$8.65M

Similar funds

Glazer Capital LLC's Q4 2022 Portfolio in Review

As of Q4 2022, Glazer Capital LLC held 821 positions worth $3.86B, down 29% from $5.46B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glazer Capital LLC withdrew a net $1.68B in Q4 2022, closing 295 positions and reducing 93 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Financials at 69% of assets, up from 64% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glazer Capital LLC opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $41M.

  • Glazer Capital LLC's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 360,496 shares worth $41M.
  • Glazer Capital LLC added most to Jaws Mustang Acquisition Corp. in Q4 2022, an estimated $52.5M increase.
  • Glazer Capital LLC's biggest Q4 2022 reduction was Envoy Medical, cutting an estimated $34M.
  • Glazer Capital LLC fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $187M.
  • Glazer Capital LLC's ten largest holdings make up 19% of its $3.86B portfolio in Q4 2022.
  • Glazer Capital LLC opened 112 new positions and closed 295 in Q4 2022.
  • Glazer Capital LLC's portfolio value fell 29% quarter-over-quarter to $3.86B.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.